Lazard Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
Lazard Asset Management's IRMD Position: Q3 2026 in Review
Lazard Asset Management reduced its iRadimed (IRMD) stake by 79% in Q3 2026, selling an estimated $3.47M and leaving 10,078 shares worth $869K. The position accounts for ﹤0.01% of the portfolio, ranked #1237.
Lazard Asset Management first reported a position in IRMD in Q3 2019 and has held it in 27 quarters since. The position peaked at $4.71M in Q1 2026. 212 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.
- Lazard Asset Management held 10,078 shares of iRadimed worth $869K as of Q3 2026.
- Lazard Asset Management sold 38,637 iRadimed shares in Q3 2026, an estimated $3.47M.
- iRadimed made up ﹤0.01% of Lazard Asset Management's portfolio in Q3 2026, its #1237 holding.
- Lazard Asset Management first reported a position in iRadimed in Q3 2019 and has held it in 27 quarters since.
- Lazard Asset Management's iRadimed position peaked at $4.71M in Q1 2026.
- 212 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.
Based on Lazard Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.